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Pre-transpiantation assessment of renal viability with 31P magnetic
resonance spectroscopy. As acute tubular necrosis (ATN) is still an
important cause for postoperative malfunction of renal grafts, it would be
useful to have a method predicting such a complication. We investigated
the possibility to predict ATh by measuring the ratio of phosphomo-
noesters (PME, largely consisting of adenosine monophosphate) and
inorganic phosphate (Pi) in the renal tissue, using 31P magnetic resonance
spectroscopy (MRS) during the cold ischemia period. Assuming that this
ratio reflects the tissue high-energy phosphate status, we studied five
kidneys from living related donors (LRD), 28 kidneys from heart beating
donors (HBD) and nine kidneys from non-heart beating donors (non-
HBD). All kidneys were preserved with a phosphate free solution. We
found an inverse relation between the time of 31P MRS and the PME/Pi
ratio, suggesting a graded decay of tissue high energy phosphates during
cold ischemia. The PME/Pi ratio was highest in grafts from LRD (2.65
0.50, no ATN), intermediate in grafts from HBD (1.65 0.41, 21% ATN)
and lowest in those derived from non-HBD (1.05 0.47, 56% ATN). The
differences in PME/Pi ratio between the groups was statistically significant
(P < 0.01). Moreover, the ratio was significantly lower in grafts developing
ATN (1.73 0.41 vs. 1.35 0.29 in the HBD group, 1.41 0.24 vs. 0.76
0.36 in the non-HBD group, P < 0.05). These observations point to a
general relation between the pre-transplant kidney PME/Pi ratio and the
development of ATN. However, the predictive value of a low PME/Pi
ratio was too low (36%) to reliably predict development of ATN in
individual cases. Extrapolation of the PME/Pi ratio to the time of
nephrectomy increased the predictive value to 67%.
In about 30% of all renal transplantations the graft shows a
delayed function, whereas in about 5% the transplant never starts
functioning at all [1]. When organs of donors who have been in
shock or have experienced a cardiac arrest are used, the incidence
of primary malfunction due to acute tubular necrosis (ATN)
increases. In kidneys derived from non- heart beating donors, the
percentage of delayed function is about 75%, while 12.5% will
never function [2]. Apart from the condition of the donor, factors
such as the procedure of the explantation and preservation, the
type of preservation fluid, the duration of cold and warm isch-
emia, and the condition of the recipient may determine the
postoperative function of the graft. A non-invasive method to
predict A1'N before transplantation could be helpful in the
management of the patient after implantation.
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During cold storage of the graft, the high-energy phosphates
adenosine triphosphate (ATP) and adenosine diphosphate (APP)
are degraded [3, 4]. This is reflected by an increase in adenosine
monophosphate (AMP) and inorganic phosphate (Pi). AMP is
catabolized to adenosine and inorganic phosphate, adenosine to
inosine and this finally to hypoxanthine. After reperfusion, hypo-
xanthine serves as an oxidable substrate for xanthine oxidase,
whereby the free radical superoxide is produced within a few
minutes [5]. This sequence of events may lead to organ damage
and dysfunction through several mechanisms. Lack of ATP and
APP may damage the cell by restraining energy needing pumps,
like the Na-K-ATPase, which may cause cell swelling [3]. Further-
more, adenosine is a powerful renal vasoconstrictor [61, and might
be one of the factors leading to ATN. Finally, free radicals like
superoxide can disrupt cell function in several ways, such as by
inactivating Na-K-ATPase, degradation of DNA and interrupting
the lipid bilayer of the cell membrane [3]. Consequently, it is
conceivable that the levels of ATP and its breakdown products in the
preserved graft are related to the postoperative function of the graft.
31P magnetic resonance spectroscopy (3P MRS) is a non-
invasive technique which allows in vitro measurement of relative
or absolute tissue concentrations of phosphorus containing me-
tabolites, such as ATP, AMP and Pi. Bretan et al have used 31P
MRS to study kidney graft viability [7]. They found a lower
phosphomonoester/inorganic phosphate ratio (PME!Pi ratio) in
kidneys showing delayed graft function due to ATN. The PME
peak in a 31P MR spectrum is largely formed by AMP. A reduced
PME/Pi ratio could therefore be due either to a reduced AMP
content or an increased Pi concentration, both of which have been
demonstrated by biochemical analysis in ischemic kidneys [8]. The
results of 31P MRS measurements in kidney grafts appear to be
dependent on the Pi content of the preservation fluid, as it has
been found that lower PME/Pi ratios are measured in kidneys
preserved in fluid with a high free phosphate content (Euro-
Collins, [Pi] 57 mmol/liter) compared to organs preserved in fluid
with a lower Pi content (University of Wisconsin fluid, [Pi] 25
mmol/liter) [9]. This was confirmed by Ciancabilla et al, who
found an inverse relation between PME/Pi ratio and the preser-
vation fluid phosphate content in a study in rabbits [10]. These
authors concluded that it is necessary to establish reference values
for each type of preservation fluid.
We therefore decided to perform 31P MRS measurements in
kidneys preserved in a non-phosphate containing preservation
fluid. Histidine-tryptophan-ketoglutarate (HTK) is such a fluid,
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with a post-operative graft function at least comparable to that
obtained with the UW solution [11. The goal of this study was to
determine the relation between PME/Pi ratio in HTK fluid
preserved kidneys and direct postoperative graft dysfunction due
to ATN in a prospective fashion.
Methods
Donors and recipients
Forty-two kidneys were derived from 33 donors: 5 from living
related donors (LRD), 28 from 22 heart beating donors (HBD)
and 9 from 6 non-heart beating donors (non-HBD). The age of
the donors ranged from 7 to 71 years. Causes of death in the HBD
group were: intracerebral bleeding (N = 7), cerebral ischemia(N = 6) and skull trauma (N = 9). Based on the presence of a
cardiac arrest (initial recovery, N = 3) and/or a serum creatinine
concentration >120 mol/liter (N = 4), we divided the HBD
group into a group with an unfavorable (7 kidneys from 5 donors)
and a favorable (21 kidneys from 17 donors) prognosis concerning
direct post-operative graft function. Ten nephrectomies were
performed in our hospital, and 12 elsewhere in the Eurotransplant
region. The causes of death in the non-HBD group were: intra-
cerebral bleeding (N = 1), primary cardiac arrest (N = 1) and
skull trauma (N = 4). Five donors experienced a prolonged period
of shock in the hours before nephrectomy and in one the serum
creatinine concentration was >120 mol/liter. Five non-HBD
came from our hospital and were treated before the cardiac arrest
on an intensive care unit. One kidney came from a donor in
Maastricht, the Netherlands, who sustained a primary cardiac
arrest upon arrival on the emergency ward. All non-HBD kidneys
were perfused in situ using a double balloon triple lumen catheter
as described by Booster et a!. [2]. Warm ischemia time in these
kidneys varied between 25 and 45 minutes. All kidneys were
perfused with HTK (Custodiol) and packed according to stan-
dard Eurotranspiant instructions.
Twenty-eight implantations were performed in our hospital: 5
of 5 transplants from LRD, 20 of 28 from HBD and 3 of 9 from
non-HBD. All recipients in our hospital were adults (ages ranging
from 18 to 64 years). The immunosuppressive protocol in our
patients consisted of cyclosporine A and low dose prednisone.
Post-operative function was determined by urine production and
serum creatinine determinations. To detect rejection and vascular
or urological complications, duplex-echography and ssmTc
MAG3 scintigraphy were performed bi-weekly in all patients in
the first two weeks. In case of persisting oligo- or anuria, a renal
biopsy was taken after one week. The other 14 kidneys were
transplanted within the Eurotransplant region, mostly in adults.
Different immunosuppressive protocols were used in the recipi-
ents of these grafts. Information on their postoperative course was
obtained by questionnaire. Delayed graft function due to ATN
was defined as the necessity of dialysis in the first week after
transplantation, after exclusion of other causes for dysfunction,
like hyperacute rejection, vascular thrombosis or urinary leakage.
31p MRS measurements
31P MRS was performed during the cold ischemia preservation
period, on a Philips gyroscan S15, operating at 1.5 Tesla. Prior to
31P MRS, the magnetic field homogeneity was optimized by
shimming on the H20 proton signal, using the regular head coil
provided by the manufacturer. For 31P MRS we used a double
Helmholz coil with two loops of 15 cm, which was placed
octagonally inside the regular head coil. We used a frequency-
modulated adiabatic rapid half passage pulse as detection pulse
(adiabate pulse length 3 msec). This pulse created a non-selective
90 degree excitation inside the whole coil. The kidney remained in
its sterile bag filled with HTK solution. This bag was placed into
another plastic bag filled with ice to cool the organ. Care was
taken to place all kidneys inside the coil in approximately the
same position. Partial saturation spectra with a repetition time of
2000 msec, 256 acquisitions, 3000 Hz sample frequency and 2048
sample points were recorded. The total examination time was 30
minutes. The averaged free induction decays were zero filled to
4096 data points and processed with a convolution difference
procedure (150 Hz) and exponential multiplication (6 Hz). After
Fourier transformation, a linear phase correction was applied.
Six 31P peaks were identified for fitting: the phosphomonoester
peak (PME), the inorganic phosphate peak (Pi), the phosphodi-
ester peak (PDE), and three phosphoryl peaks of adenosine
triphosphate (y, a and /3 ATP). Individual 31P spectra were fitted
by Gaussian lineshapes with a least squares method (NMR1
program, New Methods Research, Syracuse, New York, USA) to
determine chemical shifts and metabolic peak integrals. Since the
ATP resonances were often hard to detect or showed a low signal
to noise ratio (<5), only the PME/Pi ratio was used for calcula-
tions.
Statistics and calculations
Patients were classified as recipients of kidneys from LRD,
HBD and non-HBD, showing either immediate or delayed graft
function. Data are expressed as the mean standard deviation.
Analysis of differences in mean values in the three groups (LRD,
HBD and non-HBD) was performed by one-way analysis of
variance (ANOVA). If variation ratios were statistically significant
(P < 0.05), the differences between the means were analyzed by
two-tailed Student's t-test for unpaired observations using Bon-
ferroni's protection. Differences between subgroups of patients
with or without ATN were tested for statistical significance by the
two-tailed Student's t-test.
We also performed linear regression and correlation analysis
for PME/Pi and the time between nephrectomy and 31P MRS
(time to scanning). To describe the natural time course of the
changes in PME/Pi ratio in human kidney grafts, we restricted this
analysis to HBD-derived kidneys showing immediate graft func-
tion. On the basis of this analysis, we extrapolated the PME/Pi
ratio to the time of nephrectomy as well as implantation. Follow-
ing this analysis, the differences between the groups were tested
again for statistical significance as described above. Sensitivity,
specificity, positive and negative predictive values of the 31P MRS
method in predicting post-transplant graft dysfunction due to
ATN were calculated according to Bayes theorem [111.
Results
Figure 1A shows a typical 31P MR spectrum of a kidney from a
living related donor, measured within the first hour after nephrec-
tomy. This kidney started to function immediately after implan-
tation. Figure lB shows a typical spectrum of a kidney with
delayed graft function. The ATP peaks are not visible and the
PME/Pi ratio is much lower then in Figure 1A. This kidney was
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Fig. 1. A. 31P MRS of a kidney perfused with
HTK during cold storage, derived from a living
related donor with immediate function after
implantation. Abbreviations are: PME,
monophospate peak, mainly formed by AMP;
Pi, inorganic phosphate peak; PDE,
phosphodiester peak. ATP is represented in the
a- and /3- peak, and ADP in the y and a
peaks. B. 31P MRS of a kidney perfused with
HTK during cold storage derived from a non-
heart beating donor; the kidney suffered from
severe ATN after transplantation. In contrast to
the left hand panel no y-, a- and /3-peaks are
detectable, and the Pi peak is higher than the
PME peak.
Table 1. Results of PME/Pi ratio, measured and extrapolated
N
Measured
PME/Pi
Extrapolated
Time to scanning Cold ischemia timePME/Pi
nephrectomy
PMEIPi
implantation hours
LRD 5 2.56 0,50ab 2.59 0•50ab 2.53 050ab 1 0 2 0
HBD 28 1.65 0,41b 2.03 029b 1.25 0.38" 14 10 28 8
Non-HBD 9 1.05 0.47 1.28 0.40 0.55 0.42 8 9 26 5
HBD ATh— 22 1.73 0.41c 2.21 0.29c 1.21 O.29c 13 11 28 9
HBD A1'N+ 6 1.35 0.29 1.89 0.18 0,85 0.27 15 9 29 6
Non-HBD ATN— 4 1.41 024d 1.60 0.24 0.76 0.24" 5 1 23 3
Non-HBD ATN+ 5 0.76 0.36 1.11 0.41 0.17 0.30 11 11 29 5
Abbreviations are: LRD, living related donor; HBD, heart beating donor; ATN, acute tubular necrosis; PME, phosphomonoesters; Pi, organic
phosphate; N, number of observations.
a Difference between LRD and HBD, P < 0.01 (ANOVA)
b Difference between LRD or HBD and non-HBD, P < 0.01 (ANOVA)
Difference between (HBD, ATN—) and (HBD, ATN+), P < 0.05 (Mann-Whitney test)
"Difference between (non-HBD, Am—) and (non-HBD, ATN+), P < 0.05 (Mann-Whitney test)
derived from a non-heart beating donor and 31P MRS was
performed 30 hours after nephrectomy; it started to function after
one month of anuria.
In all recipients of LRD kidneys immediate post operative
function was observed. Delayed graft function due to ATN was
found in 21% in the HBD group, and in 56% in the non-HBD
group. As shown in Table 1 and Figure 2A, kidneys from LRD
had a higher mean PME/Pi ratio than kidneys from HBD or
non-HBD (P < 0.01). Also, the mean value in the HBD group was
greater than in the non-FIBD group (P < 0.01). Moreover, both
within the HBD and the non-HBD group, kidneys from patients
with ATh had a lower mean PME/Pi ratio than those with
immediate function (P < 0.05).
Figure 3 shows the PME/Pi ratios of the kidneys with immedi-
ate function, derived from HBD, plotted against the time to
scanning. In this subgroup of kidneys, we found a significant
inverse relation between these variables (N = 22; slope —0.028;
r =
—0.74, P < 0.001). We also performed repeated measure-
ments in two kidneys derived from a single non-heart beating
donor (Fig. 4). As these kidneys were not implanted because of
bad preservation conditions, we were able to measure PMEIPi
ratios up to 180 hours after nephrectomy. Although performed at
a much lower initial PMEIPi ratio, we also found a linear decay in
PMEIPi ratio with increasing time to scanning in this experiment.
The slope of the line in each kidney was —0.024, which is
remarkably close to the value observed in the HBD group.
As the times to scanning as well as cold ischemia periods of the
various transplantation procedures were quite different (Table 1),
we extrapolated PME/Pi values to the time of nephrectomy as well
as implantation according to the relation obtained in the HBD
group. The extrapolation to the time of nephrectomy hardly
affected the PME/Pi ratio of the LRD kidneys, as they were
P1
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Fig. 2. PME/Pi ratios measured and calculated for the time of nephrectomy and implantation, respectively. Abbreviations are: LRD, living related donors;
HBD, heart-beating donors; non-HBD, non heart-beating donors; ATh, acute tubular necrosis. Open symbols represent kidneys with immediate graft
function after implantation, closed symbols identi' kidneys with delayed graft function.
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measured immediately after nephrectomy and implanted within
two hours. As the differences in time to scanning were the greatest
in the HBD group, the extrapolation caused a decrease in
variation coefficient from 25% (measured PME/Pi ratios) to 14%
(PME/Pi ratios estimated at the time of nephrectomy). When
calculated for the time of nephrectomy, the difference in mean
PME/Pi ratio for LRD and HBD kidneys decreased (compare Fig.
2A and B; Table 1). In general differences in group means for the
PME/Pi ratio increased after extrapolation to the time of implan-
tation (Table 1).
Table 2 shows the sensitivity, specificity, efficacy and predictive
values of the test for the measured as well as extrapolated PMEIPi
values of the HBD group. The best predictive values of 31P MRS
for detecting ATN in HBD-derived kidneys were found in the
data extrapolated to the time of nephrectomy. The number of
kidneys derived from non-HBD was too low to perform these
calculations for this group.
We also classified the HBD kidneys according to the presence
or absence of cardiac arrest or increased serum creatinine level in
the donor. We did not find a difference in measured or extrapo-
0 100 200
Measured Nephrectomy Implantation
Threshold 1.71 1.75 0.95
Sensitivity 83% 67% 67%
Specificity 59% 91% 77%
Efficacy 53% 86% 75%
Positive predictive value 36% 67% 44%
Negative predictive value 93% 91% 89%
lated PME/Pi between the two prognostic groups: when extrapo-
lated to the time of nephrectomy, mean PME/Pi in the kidneys
from the unfavorable prognostic group was 1.78 0.49 (N = 7),
as opposed to 1.60 0.38 (N = 21) in the potentially favorable
group. In the former group delayed graft function was seen in 2
out of 7 kidneys (29%), while this was the case in 4 of the 21 grafts
(19%) in the former group (NS). We were not able to find a
significant relation between the incidence of A1'N and the length
of the cold ischemia period in our small group of patients.
The results of paired 31P MRS measurements (N = 9) in
LRD HBD non-HBD
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Fig. 3. Relation between PME/Pi ratio and time to scanning (period between
nephrectomy and 31P MRS) in kidney grafts derived from heart beating
donors which functioned immediately after implantation.
Time to scanning, hours
Fig. 4. Repeated measurements in two kidneys from the same (non-heart
beating) donor within the first 180 hours after nephrectomy.
TabLe 2. Sensitivity, specificity, efficacy and predictive values of 31P
NMR for detecting acute tubular necrosis in kidneys derived from heart
beating cadaveric donors
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PME/Pi ratio, left kidney
Fig. 5. Results of PME/Pi measurements in nine pairs of kidneys. The
dotted line is the line of identity. Open symbols indicate pairs of kidneys
of which the kidney with the lowest PME/Pi ratio showed delayed function
due to acute tubular necrosis.
kidneys derived from the same donor are shown in Figure 5. In
three pairs, the difference between the lowest and highest PME/Pi
was negligible. Both kidneys derived from these donors func-
tioned immediately. In the other six pairs, the difference between
lowest and highest PMEIPi ratio varied from 15% to 43%. In two
of these pairs, both kidneys functioned immediately. In the
remaining pairs, one kidney showed immediate and one delayed
function, the latter always occurring in the kidney with the lowest
PME/Pi value.
Discussion
The main finding of the present study is that there appears to be
a relation between a measure of kidney graft high energy phos-
phate status, the PME/Pi ratio, and graft dysfunction due to ATN.
The mean PME/Pi ratio was highest in kidneys derived from LRD
(no Am), intermediate in those derived from HBD (21% ATN)
and lowest in kidneys originating from non-HBD (56% ATN).
Moreover, the mean PME/Pi ratio in the HBD and non-HBD
group was lower in kidneys developing ATN. In contrast, we were
unable to find a relation between donor-related prognostic factors
and post-operative graft function of HBD-derived kidneys, nor
did we find a relation between ATh and cold ischemia time.
The dissimilar PMEIPi ratios observed in the three groups are
most likely due to differences in the clinical condition of the
donors, which was obviously much better in LRD than in non-
HBD, as well as variations in warm ischemia time. Despite the
overall agreement between the PMEIPi ratio and the occurrence
of ATh in groups of patients, 31P MRS appeared to be of limited
value in predicting development of ATN in individual cases. The
values for the PMEIPi ratio were widely scattered in all groups
(Fig. 2A), and a considerable overlap occurred within the groups
for kidneys showing either direct or delayed graft function. As a
consequence, the positive predictive value of a PME/Pi ratio
<1.71 with respect to the occurrence of ATN was only 36%
(Table 2). Because we found an inverse relation between PMEIPi
ratio and the time between nephrectomy and 31P MRS, part of the
scatter and overlap could be due to the considerable differences in
these times. When we eliminated this factor by extrapolation of
the PME/Pi ratios to the time of nephrectomy, the overlap and
scatter were indeed reduced (Table 1, Fig. 3B), and the positive
predictive value of the PMEIPi ratio in HBD-derived kidneys
increased to a more acceptable level of 67%.
As the cold ischemia time could be an independent risk factor
for ATN, we also extrapolated the PME/Pi ratio to the time of
implantation. This procedure, however, did not improve the
usefulness of the method, as the positive predictive value re-
mained virtually unchanged (44%). These findings seem to indi-
cate that the high energy phosphate status of the graft at the time
of nephrectomy is a more important determinant of postoperative
function than at the time of implantation. However, this conclu-
sion is based on indirect, extrapolated data, and hence should be
considered with caution.
A considerable proportion of kidneys, both in the HBD and
non-HBD groups, showed direct function at PME/Pi ratios con-
siderably lower than in the LRD group. This clearly suggests that
other factors than the high-energy phosphate status as assessed by
31P MRS determine whether ATN will occur. It should be
considered, for instance, that terminal products of the ATP
degradation pathway, such as hypoxanthine, could be of greater
pathogenetic importance [5]. Unfortunately, these substances can
not be measured by 31P MRS because they do not contain
phosphorus. Hypoxanthine levels could be measured in pre-
implantation kidney graft biopsies by techniques such as high
performance liquid chromatography. Results of such measure-
ments, however, would not be available rapidly enough to guide
clinical decisions in renal transplantation.
At this point, it should also be noted that the occurrence of
ATh in transplanted kidneys is determined by a multitude of
factors of which several take place at the time of or even after
implantation [12]. These include the volume status of the receiver,
the use of scavengers like mannitol, the administration of calcium
entry blockers and the skill of the surgeon [13]. Moreover, the
diagnosis of A1'N after transplantation is generally based on
clinical findings, and often not proven by histology. Early rejection
and technical problems may imitate ATN. Although we did our
best to exclude these patients from our study, these factors will
limit the predictive value of any test which is performed before
implantation.
Our observation of a graded decay of the PMEIPi ratio during
cold storage of kidneys (Figs. 3 and 4) disagrees with a study of
Bretan et al [7], who failed to find a relation between cold
ischemia time and PMEIPi ratio in human kidneys. The discrep-
ancy between the two studies may be related to the difference in
preservation fluid. We used a phosphate free solution, whereas
Bretan et al studied kidney grafts perfused with a phosphate
containing solution (Collins-2). This would agree with the obser-
vation that these authors did find a relation between cold ischemia
and PME/Pi ratio in a study in dogs, in which they used a
phosphate free preservation fluid as in the present study [7, 14J.
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Preliminaiy data published by Pomer, Hull and Mohring agree
with the notion of a gradual decay of high-energy phosphates in
human kidney grafts [15].
A further difference between the two studies in humans is that
the mean PME/Pi ratio in HBD-derived grafts reported by Bretan
et al was lower (0.62 0.45) than in our study (1.65 0.41). This
confirms observations of Lietzenmayer et a! [9] and Ciancabilla et
a! [10], who found an inverse relation between the PME/Pi ratio
and the phosphate content of various preservation fluids. As it has
been shown that high phosphate signals originating from the
preservation solution may interfere with a correct determination
of the concentration of renal high-energy phosphate metabolites
[14], it is conceivable that the use of a phosphate free preservation
fluid could improve the performance of 31P MRS in predicting
ATN. However, we could not confirm this notion: the sensitivity
(0.67) and specificity (0.91) of the PME/Pi ratio in predicting ATN
were similar as those reported by Bretan et a! [7] in kidneys
preserved in a phosphate containing solution (0.73 and 0.84,
respectively).
In view of the general relation between the PME/Pi ratio and
the occurrence of ATN, one might consider to avoid implanting
kidneys with a low PMEIPi ratio into patients with other risk
factors, like a poor HLA match, a high level of lymphocytotoxic
antibodies or preexisting cardiovascular disease. More impor-
tantly, in view of the possible harmful effect of cyclosporin A in
grafts suffering from ATN [16], this drug should perhaps be
avoided lower dosed in recipients of kidneys with a low pre-
transplant PME/Pi ratio. Whether such an approach will improve
the clinical outcome of kidney transplantations remains, however,
to be established.
In conclusion, we found a general relation between the level of
the pre-transpiant PME/Pi ratio measured by 31P MRS and the
development of ATN in kidney grafts preserved in a phosphate
free solution. At present, the predictive value of this method
(36%) is too small to predict development of ATN reliably in
individual cases. However, extrapolation of the PME/Pi ratio to
the time of nephrectomy may improve the usefulness of the
method.
Reprint requests to R. J. Hené, Department of Nephrology and Hyperten-
sion, Room F03.226, Universiiy Hospital Utrecht, P.O. Box 85500, 3508 GA
Utrecht, The Netherlands.
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